The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases.
作者： Britain Baker , Luísa Eça Guimarães , Lucija Tomljenovic , Nancy Agmon-Levin , Yehuda Shoenfeld
DOI: 10.1517/14740338.2015.1073710
关键词:
摘要: Introduction: With the safety of human papilloma virus vaccine (HPVv) being questioned, this article aims to assess risks and benefits commercially available HPVv. Within last decade, two vaccines (Gardasil Cervarix) have been put on market prevent infection with most oncogenic HPV subtypes. Both contain aluminum adjuvants that are meant cause a hyper stimulated immune response infection.Areas covered: The purpose paper is consider these based data from U.S. Vaccine Adverse Event Reporting System (VAERS) case reports.Expert opinion: current HPVv both effective generally safe. However, it should be noted autoimmune side effects reported in several studies. Further research done understand relationship between autoimmunity.
sci-hub.se 参考文章(62)
Jonathan R. CARTER, Zongqun DING, Barbara R. ROSE, HPV infection and cervical disease: a review. Australian & New Zealand Journal of Obstetrics & Gynaecology. ,vol. 51, pp. 103- 108 ,(2011) , 10.1111/J.1479-828X.2010.01269.X
Shoenfeld Y, Aron-Maor A, Vaccination and Autoimmunity—‘vaccinosis’: A Dangerous Liaison? Journal of Autoimmunity. ,vol. 14, pp. 1- 10 ,(2000) , 10.1006/JAUT.1999.0346
Nizar Souayah, P.A. Michas-Martin, Abu Nasar, Nataliya Krivitskaya, Hussam A. Yacoub, Hafiz Khan, Adnan I. Qureshi, Guillain–Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006–2009 Vaccine. ,vol. 29, pp. 886- 889 ,(2011) , 10.1016/J.VACCINE.2010.09.020
Costanzo Natale, Teresa Giannini, Alberta Lucchese, Darja Kanduc, Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences. Immunology and Cell Biology. ,vol. 78, pp. 580- 585 ,(2000) , 10.1046/J.1440-1711.2000.00949.X
HF Soldevilla, SFR Briones, SV Navarra, Systemic lupus erythematosus following HPV immunization or infection Lupus. ,vol. 21, pp. 158- 161 ,(2012) , 10.1177/0961203311429556
Sin Hang Lee, Detection of human papillomavirus (HPV) L1 gene DNA possibly bound to particulate aluminum adjuvant in the HPV vaccine Gardasil Journal of Inorganic Biochemistry. ,vol. 117, pp. 85- 92 ,(2012) , 10.1016/J.JINORGBIO.2012.08.015
Kristine K. Macartney, Clayton Chiu, Melina Georgousakis, Julia M. L. Brotherton, Safety of Human Papillomavirus Vaccines: A Review Drug Safety. ,vol. 36, pp. 393- 412 ,(2013) , 10.1007/S40264-013-0039-5
Deirdre Therese Little, Harvey Rodrick Grenville Ward, Adolescent Premature Ovarian Insufficiency Following Human Papillomavirus Vaccination: A Case Series Seen in General Practice Journal of investigative medicine high impact case reports. ,vol. 2, pp. 2324709614556129- 2324709614556129 ,(2014) , 10.1177/2324709614556129
Philip E. Castle, Beyond Human Papillomavirus: The Cervix, Exogenous Secondary Factors, and the Development of Cervical Precancer and Cancer Journal of Lower Genital Tract Disease. ,vol. 8, pp. 224- 230 ,(2004) , 10.1097/00128360-200407000-00011
L L Villa, R L R Costa, C A Petta, R P Andrade, J Paavonen, O-E Iversen, S-E Olsson, J Høye, M Steinwall, G Riis-Johannessen, A Andersson-Ellstrom, K Elfgren, G von Krogh, M Lehtinen, C Malm, G M Tamms, K Giacoletti, L Lupinacci, R Railkar, F J Taddeo, J Bryan, M T Esser, H L Sings, A J Saah, E Barr, High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up British Journal of Cancer. ,vol. 95, pp. 1459- 1466 ,(2006) , 10.1038/SJ.BJC.6603469